1. Home
  2. NMRA vs SBT Comparison

NMRA vs SBT Comparison

Compare NMRA & SBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NMRA
  • SBT
  • Stock Information
  • Founded
  • NMRA 2019
  • SBT 1984
  • Country
  • NMRA United States
  • SBT United States
  • Employees
  • NMRA N/A
  • SBT N/A
  • Industry
  • NMRA
  • SBT Savings Institutions
  • Sector
  • NMRA
  • SBT Finance
  • Exchange
  • NMRA Nasdaq
  • SBT Nasdaq
  • Market Cap
  • NMRA 287.6M
  • SBT 249.0M
  • IPO Year
  • NMRA 2023
  • SBT 2017
  • Fundamental
  • Price
  • NMRA $1.01
  • SBT $4.84
  • Analyst Decision
  • NMRA Buy
  • SBT
  • Analyst Count
  • NMRA 8
  • SBT 0
  • Target Price
  • NMRA $10.14
  • SBT N/A
  • AVG Volume (30 Days)
  • NMRA 1.2M
  • SBT 62.9K
  • Earning Date
  • NMRA 03-03-2025
  • SBT 04-23-2025
  • Dividend Yield
  • NMRA N/A
  • SBT N/A
  • EPS Growth
  • NMRA N/A
  • SBT N/A
  • EPS
  • NMRA N/A
  • SBT 0.04
  • Revenue
  • NMRA N/A
  • SBT $66,063,000.00
  • Revenue This Year
  • NMRA N/A
  • SBT N/A
  • Revenue Next Year
  • NMRA N/A
  • SBT N/A
  • P/E Ratio
  • NMRA N/A
  • SBT $122.00
  • Revenue Growth
  • NMRA N/A
  • SBT N/A
  • 52 Week Low
  • NMRA $0.95
  • SBT $4.40
  • 52 Week High
  • NMRA $17.19
  • SBT $5.97
  • Technical
  • Relative Strength Index (RSI)
  • NMRA 26.42
  • SBT 56.03
  • Support Level
  • NMRA $1.12
  • SBT $4.80
  • Resistance Level
  • NMRA $1.23
  • SBT $4.91
  • Average True Range (ATR)
  • NMRA 0.10
  • SBT 0.05
  • MACD
  • NMRA 0.04
  • SBT 0.01
  • Stochastic Oscillator
  • NMRA 2.18
  • SBT 80.56

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has rapidly scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. The company expects to continue to progress in the development of its pipeline with the planned initiation of multiple clinical trials across its programs over the next 12 to 18 months, which supports numerous anticipated data readouts.

About SBT Sterling Bancorp Inc.

Sterling Bancorp Inc is a unitary thrift holding company. Its primary business is the operation of its wholly-owned subsidiary, Sterling Bank, through which it offers a range of loan products to the residential and commercial markets, as well as retail banking services. The products and services offered by the bank include saving and current accounts, demand and term deposits, payment cards, trade finance, fund transfer, treasury and cash management. It provides services such as construction loans, residential real estate, commercial real estate, commercial lines of credit and other consumer loans.

Share on Social Networks: